If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...

Among 196 doctors who prescribed clozapine, 64% said the positive aspects of the REMS certification process outweighed the ...

Even under the best of circumstances, remembering to take a daily pill can be a challenge. For someone living with ...

Our study investigated the brain circuits involved in psychosis-a condition characterized by delusions, hallucinations, ...

Eric Amavizca-Ayala came to the United States as a small child and has two brothers living in Manteca who are United States ...

Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the ...

Anavex Life Sciences Corp. expects feedback from the European Medicines Agency on blarcamesine for Alzheimer's Disease this ...

In a notable Genomic Press research report, researchers at the Aristotle University of Thessaloniki have uncovered a significant presence of manic symptoms in patients with schizophrenia spectrum ...

Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, outlines the progression of treatment approaches for comorbid ...

Andrew Pines, MD, MA, a resident in the Department of Psychiatry at Brigham and Women’s Hospital and a researcher in the ...

Upward telemedicine trends in schizophrenia treatment were rapid after the COVID-19 pandemic, particularly in state-operated agencies.